On March 9, 2026, Tenacia and Rapport Therapeutics announced an exclusive licensing agreement under which Tenacia obtained exclusive rights to develop and commercialize Rapport’s RAP‑219 in Greater China, in a deal worth up to $328 million. Under the terms of…
On May 26, 2026, Henlius (2696.HK) announced that the first patient has been dosed in China in a randomized, double-blind, multicentre, parallel-controlled Phase 2/3 clinical trial evaluating its self-developed recombinant anti-EGFR mAb pimurutamab (HLX07) in combination with the anti-PD-1 mAb…
On May 21, Boehringer-Ingelheim announced that a new indication for its lung cancer drug Zongertinib has been officially approved for use as a first-line monotherapy in adult patients with advanced non-small cell lung cancer harboring HER2 tyrosine kinase domain-activating mutations.…
On May 26, according to the latest announcement on the CDE official website, ALG-000184 tablets submitted by Fortrea were proposed for breakthrough therapy designation, with the indication being treatment‑naïve or untreated chronic hepatitis B virus (HBV) infection, aiming to achieve…
RAS is one of the most frequently mutated genes in human cancers. As an important member of the small GTPase family, RAS proteins act as “molecular switches,” cycling between the GTP-bound “ON” active state and the GDP-bound “OFF” inactive state.…
Currently, Class 1.1 innovative TCM drugs for bronchial asthma chronic persistent phase (Cold Wheezing Syndrome) remain scarce.YRPG’s ZGZHR-061 Granules target this condition, fitting respiratory chronic disease needs. The drug first filed for a clinical trial on March 13, 2026, and…
Major MS Data Presented at ECTRIMS: Long-Term OCREVUS Safety Confirmed; Fenebrutinib Phase II Shows Near-Complete Disease Suppression Introduction At the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Roche presented a substantial…
Your choices can be overwhelming. You’ve got over a dozen options to pick from — each with its pros and cons. When it comes right down to it, the best birth control is the method you’re most likely to use. But…